Overview: Recent Developments in Sulphidopeptide Leukotriene Receptor Antagonists
- 1 June 1992
- journal article
- Published by Informa Healthcare in Current Opinion on Therapeutic Patents
- Vol. 2 (6) , 811-833
- https://doi.org/10.1517/13543776.2.6.811
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Synthesis of a new pseudopeptidoleukotriene : The first LTD4 analogue with potent agonist activityTetrahedron Letters, 1991
- Peptide leukotrienes: current status of researchJournal of Medicinal Chemistry, 1991
- Sulukast < Prop INN >Drugs of the Future, 1991
- Conformationally restricted leukotriene antagonists. Asymmetric synthesis of a nor-leokotriene D4 analog. II.Tetrahedron Letters, 1990
- SK&F-104353Drugs of the Future, 1990
- Conformationally restricted leukotriene antagonists. Stereoselective synthesis of some leukotriene D4 analogsTetrahedron, 1990
- Conformationally restricted leukotriene antagonists. Synthesis of some leukotriene D4 analogs from D-xyloseTetrahedron Letters, 1989
- The pharmacological evaluation of LY170680, a novel leukotriene D4 and E4 antagonist in the guinea‐pigBritish Journal of Pharmacology, 1989
- Conformationally restricted leukotriene antagonists. Asymmetric synthesis of some nor-leukotriene D4 analogsTetrahedron Letters, 1989
- High-affinity leukotriene receptor antagonists. Synthesis and pharmacological characterization of 2-hydroxy-3-[(2-carboxyethyl)thio]-3-[2-(8-phenyloctyl)phenyl]propanoic acidJournal of Medicinal Chemistry, 1987